Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Revenue
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H had a revenue of 620.96M in the quarter ending Jun 30, 2025, with 8.95%. This bring the company's revenue in the last twelve months to 1.19B, Decreased 21.47%. In the fiscal year ending Dec 31, 2024, Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H had annual revenue of 980.45M with 36.76% growth.